The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study
about
The safety of long-acting ß2-agonists in the treatment of stable chronic obstructive pulmonary diseaseBeta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine modelDeciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid ReceptorsThe cardiac protein αT-catenin contributes to chemical-induced asthmaClinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airwayRole for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling.For the love of paradox: from neurobiology to pharmacologyBiochemical basis of asthma therapy.Epinephrine Activation of the β2-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells.Long-Acting Beta Agonists Enhance Allergic Airway DiseaseEffects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.β-Blockers have differential effects on the murine asthma phenotype.Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study.Therapeutic options for severe asthmaChronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.β2-Adrenoceptor agonists are required for development of the asthma phenotype in a murine model.Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al.Beta-blockers: friend or foe in asthma?Management of asthma in the elderly patient.Agonizing over agonism: should asthmatics turn their beta-receptors on or off?Similarities and differences in the autonomic control of airway and urinary bladder smooth muscleA meta-analysis of the effects of β-adrenergic blockers in chronic heart failureAdvances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease.β2-adrenoreceptor Inverse Agonist Down-regulates Muscarine Cholinergic Subtype-3 Receptor and Its Downstream Signal Pathways in Airway Smooth Muscle Cells in vitro.Current concepts on the use of glucocorticosteroids and beta-2-adrenoreceptor agonists to treat childhood asthmabeta-Adrenoceptor inverse agonists in asthmaNew perspectives regarding β(2) -adrenoceptor ligands in the treatment of asthma.Initial experience using propranolol as an adjunctive treatment in children with aggressive recurrent respiratory papillomatosis.β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectives.GPCRs and arrestins in airways: implications for asthma.Ligand bias prevents class equality among beta-blockers.Noradrenaline transmission reducing drugs may protect against a broad range of diseases.Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.β2 AgonistsCardiomyocytes of the Heart and Pulmonary Veins: Novel Contributors to Asthma?Beta-Adrenergic Agonists
P2860
Q22305858-DE841252-2FAA-477B-A0EC-FDA5D12743AFQ24646260-536B2B94-6847-4DDD-8E3F-016B592E81A3Q27678139-75500CDD-7AB3-43A7-99CF-C7C0871B890DQ28388603-34322D14-027A-4832-A21D-1394947D812FQ33792699-A8FEBF65-4D5B-4CA9-9569-85C063A17C81Q33896990-E42B6370-9638-4AED-9CCE-5813A3353F64Q33975010-7D16A3B4-1825-4CD2-874A-8411B818F088Q34575920-3BF4063F-F542-421D-991D-DC19EA07CE64Q34837191-FD1D2234-4ECE-4114-B20A-A1693D591274Q35163044-FE6F5AB0-BCA8-4F4B-A67B-777AF881BA5CQ35312155-0BC272BD-C813-4266-B988-6D410D47B020Q35688187-629D7062-7FD1-48C3-8106-77F628488313Q35852118-65C9C223-D4DD-4B10-9B32-D55827EB52C1Q36111202-1663541F-C6EE-4A04-B73B-709E816F14F0Q36211207-5900AE10-CEFB-44D6-A0B5-0948354ED0F0Q36261786-8FDB777E-1816-4030-97B1-8B23FC8FDAF2Q36286252-8965AF70-3BCE-48AF-B432-98A8B2385C87Q36482653-DFE14F93-3048-402E-908F-5884663B008CQ36602201-C07F3B51-570C-492B-84E4-DD2532AF70CEQ36703892-EF48A9B6-2EE9-40FF-882E-A49639DB584AQ36744208-5191ED1B-C384-4446-91B2-48BC8DBF1F0FQ37006857-8C76B7B8-613E-43BF-B1E8-D73C07973BA0Q37027409-5C427829-AD06-4393-A513-F0D8731BD97FQ37114730-9DB5F598-CED0-486D-BB69-080F75E96F5EQ37189382-B940189D-51A6-427A-8FD1-F317075BA7FAQ37289514-D19D6FBE-7C78-4851-8F35-144CCDD96238Q37516982-2DCFB63A-B474-40BD-8DDD-938CADF24A22Q37554447-8DA6D309-24F0-43ED-8FEF-49C9A0AFB902Q37694255-AD6C3F93-13F9-47C2-9759-C12DC0D64AD2Q37732847-68D32714-F2B7-4397-8AF3-C24BC851D03FQ37822833-FBD3240A-5EE6-40F5-8D22-09FBA4797FB9Q37849276-1BF7D397-355C-4AA0-9720-B4C5289F1091Q38152743-2C773E96-8003-4CF1-911D-777F018191A3Q38167643-C979F00F-2360-420A-87CC-378925278368Q38200427-A8443EF1-28AA-4F14-B93E-0E9889B6CB43Q38255794-3C99D510-5CF7-44C2-8204-7A48011C094FQ38669392-C01B4340-C793-4EA8-B9A8-0D1567038BF6Q38791742-3186682E-61E6-4073-92B0-1B44D0B922F5Q38798374-45259EA8-81E9-4626-82A5-576FAB3E11EAQ38974241-448B3345-F6A2-4FF6-833F-BE60FD574E46
P2860
The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The safety and effects of the ...... hma: an open-label pilot study
@ast
The safety and effects of the ...... hma: an open-label pilot study
@en
type
label
The safety and effects of the ...... hma: an open-label pilot study
@ast
The safety and effects of the ...... hma: an open-label pilot study
@en
prefLabel
The safety and effects of the ...... hma: an open-label pilot study
@ast
The safety and effects of the ...... hma: an open-label pilot study
@en
P2093
P2860
P50
P1476
The safety and effects of the ...... hma: an open-label pilot study
@en
P2093
Amie E Franklin
Brian J O'Connor
Felix Shardonofsky
Michael Flashner
Rami El-Wali
Richard A Bond
Stephen Ruoss
Supria Singh
William J Garner
P2860
P304
P356
10.1016/J.PUPT.2007.07.002
P577
2007-07-17T00:00:00Z